EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Recombinant human adenovirus type 5-vectored vaccine expressing avian reovirus σC protein protects against prevalent genotype I avian reovirus in chickens

Xiyao Cui, Zhenrui Song, Defang Zhou, Liangyu Yang, Hongbo Chen, Hui Zhang, Ziqiang Cheng

Poultry Science · 2026-11 · 105 (11) · 107495

DOI: 10.1016/j.psj.2026.107495 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Poultry Science, 2026-11. Verfasst von Xiyao Cui und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Yunnan Agricultural University, Kunming 650201, China; College of Veterinary Medicine, Shandong Agricultural Universi…. Hauptthemen laut MEDLINE: Chickens, Poultry Diseases, Orthoreovirus, Avian, Viral Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shandong Agricultural University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Avian reovirus (ARV) is a globally important poultry pathogen causing substantial economic losses due to viral arthritis, enteritis and immunosuppression. Traditional vaccines based on the S1133 strain are less effective against circulating ARV variants due to genetic divergence. The σC protein is the primary antigen inducing neutralizing antibodies against ARV, making it a key target for vaccine development. Here, we constructed a recombinant human adenovirus type 5 (rHAdV5) vector vaccine expressing the σC protein of a prevalent Chinese ARV field strain (SDAU-1) and evaluated its safety, immunogenicity and protective efficacy in specific-pathogen-free (SPF) chickens. The recombinant vaccine rHAdV5-ARV-σC stably expressed the ∼36 kDa σC protein and maintained genetic stability over 13 serial passages. Immunization of 1-day-old SPF chickens with 10⁹ PFU rHAdV5-ARV-σC elicited robust ARV-specific IgG antibodies (peak titer 1:3500 at 7 days post-immunization) and significantly elevated serum IFN-γ and IL-4 levels (P < 0.05), indicating activation of both humoral and cellular immune responses. Following challenge with the SDAU-1 strain at 7 days of age, the vaccine provided an 86% (26/30) protection rate, markedly reduced viral shedding and tissue viral loads, and alleviated pathological lesions and immune organ damage compared to unvaccinated controls. These results demonstrate that rHAdV5-ARV-σC is a safe, immunogenic, and effective vaccine candidate against prevalent ARV strains, with high potential for controlling ARV infections in commercial poultry production.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChickensPoultry DiseasesOrthoreovirus, AvianViral VaccinesReoviridae InfectionsAnimalsSpecific Pathogen-Free OrganismsVaccines, SyntheticGenotypeAntibodies, ViralHumansCapsid Proteins

Stichwörter der Autor:innen

Avian reovirusImmunogenicityRecombinant adenovirus vectorVaccineσC protein

Substanzen

Viral VaccinesVaccines, SyntheticAntibodies, Viralsigma 1 protein, reovirusCapsid Proteins

Autor:innen und Institutionen

  • College of Veterinary Medicine, Yunnan Agricultural University, Kunming 650201, China; College of Veterinary Medicine, Shandong Agricultural University, Tai'an 271017, China.
  • College of Veterinary Medicine, Shandong Agricultural University, Tai'an 271017, China.
  • College of Veterinary Medicine, Yunnan Agricultural University, Kunming 650201, China.
  • School of Life Sciences, Longyan University, Longyan 364012, China.
  • College of Animal Science and Technology, Shihezi University, Shihezi 832003, Xinjiang, China.
  • College of Animal Science and Technology, Shihezi University, Shihezi 832003, Xinjiang, China; School of Life Sciences, Longyan University, Longyan 364012, China; College of Veterinary Medicine, Yunnan Agricultural Univ…

Förderung

  • Shandong Agricultural University

Zitieren

APA

Cui, X., Song, Z., Zhou, D., Yang, L., Chen, H., Zhang, H., & Cheng, Z. (2026). Recombinant human adenovirus type 5-vectored vaccine expressing avian reovirus σC protein protects against prevalent genotype I avian reovirus in chickens. Poultry Science, 105(11), 107495. https://doi.org/10.1016/j.psj.2026.107495

Vancouver

Cui X, Song Z, Zhou D, Yang L, Chen H, Zhang H, et al. Recombinant human adenovirus type 5-vectored vaccine expressing avian reovirus σC protein protects against prevalent genotype I avian reovirus in chickens. Poultry Science. 2026;105(11):107495. doi:10.1016/j.psj.2026.107495

BibTeX
@article{Cui2026,
  author = {Cui, Xiyao and Song, Zhenrui and Zhou, Defang and Yang, Liangyu and Chen, Hongbo and Zhang, Hui and Cheng, Ziqiang},
  title = {Recombinant human adenovirus type 5-vectored vaccine expressing avian reovirus σC protein protects against prevalent genotype I avian reovirus in chickens},
  journal = {Poultry Science},
  year = {2026},
  volume = {105},
  number = {11},
  pages = {107495},
  doi = {10.1016/j.psj.2026.107495}
}
Kostenlos starten →